Tazobactam
File:Tazobactam structure.svg | |
Clinical data | |
---|---|
ATC code | |
Identifiers | |
| |
CAS Number | |
DrugBank | |
E number | {{#property:P628}} |
ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
Chemical and physical data | |
Formula | C10H12N4O5S |
Molar mass | 300.289 g/mol |
WikiDoc Resources for Tazobactam |
Articles |
---|
Most recent articles on Tazobactam |
Media |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Tazobactam at Clinical Trials.gov Clinical Trials on Tazobactam at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Tazobactam
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Tazobactam Discussion groups on Tazobactam Patient Handouts on Tazobactam Directions to Hospitals Treating Tazobactam Risk calculators and risk factors for Tazobactam
|
Healthcare Provider Resources |
Causes & Risk Factors for Tazobactam |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Tazobactam is a compound which inhibits the action of bacterial beta-lactamases. It is added to the extended spectrum beta-lactam antibiotic piperacillin to produce Tazocin® or Zosyn®. It broadens the spectrum of piperacillin by making it effective against organisms that express beta-lactamase and would normally degrade piperacillin.
Tazobactam sodium is a derivative of the penicillin nucleus and is a penicillanic acid sulfone.
External links
- Pages with script errors
- Pages with broken file links
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Beta-lactamase inhibitors